The current PE ratio of AMED can't be determined, as the TTM EPS of -$0.63 is negative. The most recent PE ratio recorded for Amedisys was 934.0 in September 2023.
Over the last ten years, the average PE ratio of Amedisys has been 97.78. Over the past ten years, AMED's PE ratio was at its highest in the Jun 2023 quarter at 1,016, with a price of $91.44 and an EPS of $0.09. The Mar 2023 quarter recorded the bottom point at 21.26, with a price of $73.55 and an EPS of $3.46.
Maximum annual increase: 53.89% in 2017
Maximum annual decrease: -51.45% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 22.89 | -9.35% |
| 2021 | 25.25 | -51.45% |
| 2020 | 52.01 | 23.07% |
| 2019 | 42.26 | 31.36% |
| 2018 | 32.17 | -45.07% |
| 2017 | 58.57 | 53.89% |
| 2016 | 38.06 | N/A |
| 2015 | N/A | N/A |
| 2014 | 75.26 | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| CIVI Civitas Resources Inc | 8.14 | $7.48B |
| NHC National Healthcare Corp | 20.94 | $1.4B |
| ADUS Addus HomeCare Corp | 24.18 | $1.53B |
| CHE Chemed Corp | 30.95 | $8.47B |
| AMED Amedisys Inc | N/A | $3B |
The current price to earnings ratio of AMED can't be calculated, as its EPS of -$0.63 is negative.
As an average over the last 3 years, AMED stock has a PE ratio of 215.37.
As an average over the last 5 years, AMED stock has a PE ratio of 138.79.
In the last ten years, the Jun 2023 quarter recorded the highest quarterly PE ratio at 1,016.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.